While conventional triple assessment (clinical, needle biopsy and mamm
ography) has a high sensitivity in the diagnosis of symptomatic breast
cancer, it has limitations in defining the extent of disease within t
he breast and the axilla. The purpose of this study was to evaluate th
e clinical settings in which pre-operative magnetic resonance imaging
(MRT) may be of additional value to triple assessment. Eighty-six pati
ents with breast cancer (including one bilateral cancer) diagnosed at
triple assessment underwent preoperative contrast enhanced MRI. Based
on clinical and mammographic findings and patient's choice of treatmen
t (but not MR findings), 49 cancers were treated by wide local excisio
n, of whom 16 (33%) had resection margin involvement. Residual disease
at re-excision was detected in 8 of these 16 patients. The extent of
residual disease in the re-excision specimen correlated accurately wit
h the extent of contrast enhancement on MRI in all cases. There was go
od size correlation between histological and MRI measurement of invasi
ve tumour (r(2)=0.93) size compared with mammographic measurement of t
umour size (r(2)=0.59). MRT was also more accurate than mammography in
depicting multifocal/multicentric tumours (86% Versus 50%), intraduct
extension associated with invasive tumours and assessment of the nipp
le-retro-areolar complex. In conclusion, MRI may be of value in planni
ng definitive surgical resection of breast cancer. Its incorporation i
nto clinical use may have an impact on local recurrence rates and on t
he number of patients considered suitable for breast conservation.